CURATIS N AG (CURN) - Total Liabilities

Latest as of June 2025: CHF9.96 Million CHF ≈ $12.59 Million USD

Based on the latest financial reports, CURATIS N AG (CURN) has total liabilities worth CHF9.96 Million CHF (≈ $12.59 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CURATIS N AG (CURN) cash conversion ratio to assess how effectively this company generates cash.

CURATIS N AG - Total Liabilities Trend (2002–2024)

This chart illustrates how CURATIS N AG's total liabilities have evolved over time, based on quarterly financial data. Check CURATIS N AG liquid asset ratio to evaluate the company's liquid asset resilience ratio.

CURATIS N AG Competitors by Total Liabilities

The table below lists competitors of CURATIS N AG ranked by their total liabilities.

Company Country Total Liabilities
Bathurst Resources Ltd
F:B0R
Germany €23.69 Million
Intertek Group PLC
LSE:ITRK
UK GBX2.34 Billion
Q.BEYOND AG NA O.N. KONV.
XETRA:QBY0
Germany €37.75 Million
CDON AB
ST:CDON
Sweden Skr186.70 Million
Oceanic Iron Ore Corp
V:FEO
Canada CA$58.94 Million
Doosan Fuel Cell Co. Ltd. Pfd. Series 1
KO:33626K
Korea ₩835.48 Billion
Yunsa Yunlu Sanayi ve Ticaret AS
IS:YUNSA
Turkey TL1.52 Billion
Alithya Group Inc
NASDAQ:ALYAF
USA $218.38 Million

Liability Composition Analysis (2002–2024)

This chart breaks down CURATIS N AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CURN market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.50 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.62 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.22 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CURATIS N AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CURATIS N AG (2002–2024)

The table below shows the annual total liabilities of CURATIS N AG from 2002 to 2024.

Year Total Liabilities Change
2024-12-31 CHF9.94 Million
≈ $12.56 Million
+2200.46%
2023-12-31 CHF432.00K
≈ $546.16K
-94.08%
2022-12-31 CHF7.29 Million
≈ $9.22 Million
+1260.63%
2021-12-31 CHF536.00K
≈ $677.65K
+39.58%
2020-12-31 CHF384.00K
≈ $485.48K
-85.91%
2019-12-31 CHF2.73 Million
≈ $3.45 Million
+50.36%
2018-12-31 CHF1.81 Million
≈ $2.29 Million
-9.62%
2017-12-31 CHF2.01 Million
≈ $2.54 Million
-2.05%
2016-12-31 CHF2.05 Million
≈ $2.59 Million
+18.66%
2015-12-31 CHF1.73 Million
≈ $2.18 Million
-15.93%
2014-12-31 CHF2.05 Million
≈ $2.60 Million
-30.78%
2013-12-31 CHF2.97 Million
≈ $3.75 Million
-61.06%
2012-12-31 CHF7.62 Million
≈ $9.63 Million
+48.95%
2011-12-31 CHF5.11 Million
≈ $6.46 Million
-19.88%
2010-12-31 CHF6.38 Million
≈ $8.07 Million
+167.14%
2009-12-31 CHF2.39 Million
≈ $3.02 Million
-30.73%
2008-12-31 CHF3.45 Million
≈ $4.36 Million
-62.24%
2007-12-31 CHF9.13 Million
≈ $11.55 Million
+98.16%
2006-12-31 CHF4.61 Million
≈ $5.83 Million
-64.49%
2005-12-31 CHF12.98 Million
≈ $16.42 Million
-42.10%
2004-12-31 CHF22.42 Million
≈ $28.35 Million
+4.30%
2003-12-31 CHF21.50 Million
≈ $27.18 Million
+56.82%
2002-12-31 CHF13.71 Million
≈ $17.33 Million
--

About CURATIS N AG

SW:CURN Switzerland Drug Manufacturers - Specialty & Generic
Market Cap
$158.92 Million
CHF125.70 Million CHF
Market Cap Rank
#19609 Global
#189 in Switzerland
Share Price
CHF24.40
Change (1 day)
-1.61%
52-Week Range
CHF9.72 - CHF26.00
All Time High
CHF891.52
About

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson's disease, cyanide poisoning, digoxin toxicity, antih… Read more